Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease

BACKGROUND: High inter‐individual variability in therapeutic response to drugs used in the management of Inflammatory Bowel Disease (IBD) leads to high morbidity and high costs. Genetic variants predictive of thiopurine‐induced myelosuppression, thiopurine‐induced pancreatitis and immunogenicity of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Aliment Pharmacol Ther
Autori principali: Bangma, Amber, Voskuil, Michiel D., Uniken Venema, Werna T. C., Brugge, Harm, Hu, Shixian, Lanting, Pauline, Franke, Lude, Dijkstra, Gerard, Festen, Eleonora A. M., Weersma, Rinse K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Efficacy of a Pharmacogenetic Passport for Inflammatory Bowel Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318341/
https://ncbi.nlm.nih.gov/pubmed/32363635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15762
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi